Gland Pharma Limited
NSE:GLAND.NS
1764.55 (INR) • At close November 12, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||
| Current Assets: | ||||||||
| Cash & Cash Equivalents
| 18,394.32 | 19,088.95 | 3,158.24 | 4,918.2 | 1,694.97 | 2,364.02 | 3,728.41 | 5,330.77 |
| Short Term Investments
| 17,342.78 | 19,273.01 | 29,268.93 | 19,546.85 | 11,427.28 | 4,843.45 | 2,782.99 | 0 |
| Cash and Short Term Investments
| 18,394.32 | 38,361.96 | 32,427.17 | 24,465.05 | 13,122.25 | 7,207.47 | 6,511.4 | 5,330.77 |
| Net Receivables
| 15,586.9 | 8,715.33 | 12,514.66 | 12,726.78 | 7,767.32 | 5,520.48 | 5,307.93 | 4,178.73 |
| Inventory
| 16,552.37 | 19,453 | 11,856.67 | 12,751.68 | 7,562.79 | 9,118.76 | 5,128.3 | 3,787.19 |
| Other Current Assets
| 5,917.93 | 2,477.79 | 1,722.29 | 1,292.91 | 10.54 | 7,248.33 | 5,681.93 | 784.81 |
| Total Current Assets
| 56,451.52 | 69,008.08 | 58,520.79 | 51,236.42 | 28,462.9 | 23,574.56 | 17,321.63 | 14,081.5 |
| Non-Current Assets: | ||||||||
| Property, Plant & Equipment, Net
| 38,301.52 | 17,361.03 | 17,268.97 | 13,244.42 | 11,969.02 | 10,950.26 | 10,464.67 | 10,327.31 |
| Goodwill
| 2,422.59 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 1,122.19 | 116.61 | 125.35 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 3,544.78 | 116.61 | 125.35 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 6,559.13 | -733.66 | 2,000 | -19,477.33 | 16.61 | 13.28 | 19.5 | 0 |
| Tax Assets
| 504.37 | 958.88 | -415.05 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 1,251.14 | 1,064.41 | 836.15 | 19,957.31 | 411.86 | 697.39 | 1,488.88 | 328.64 |
| Total Non-Current Assets
| 50,160.94 | 18,767.27 | 19,815.42 | 13,724.4 | 12,397.49 | 11,660.93 | 11,973.05 | 10,655.95 |
| Total Assets
| 106,612.46 | 87,775.35 | 78,336.21 | 64,960.82 | 40,860.39 | 35,235.49 | 29,294.68 | 24,737.45 |
| Liabilities & Equity: | ||||||||
| Current Liabilities: | ||||||||
| Account Payables
| 8,626.92 | 5,873.5 | 4,628.5 | 4,007.25 | 2,490.94 | 4,461.98 | 2,918.11 | 1,892.89 |
| Short Term Debt
| 2,309.47 | 7.09 | 2.61 | 2.97 | 10.17 | 6.2 | 5.08 | 4.6 |
| Tax Payables
| 516.37 | 9.85 | 179.79 | 286.9 | 107.23 | 110.04 | 129 | 0 |
| Deferred Revenue
| 516.37 | 486.08 | 636.57 | 1,051.81 | 917.95 | 741.64 | 830.01 | 0 |
| Other Current Liabilities
| -6,612.42 | -4,958.69 | -4,255.72 | -4,230.9 | -2,427 | -4,454.15 | -3,008.42 | -1,256.54 |
| Total Current Liabilities
| 13,983.63 | 7,291.33 | 5,820.25 | 5,125.28 | 3,590.23 | 5,327.69 | 3,791.89 | 2,533.84 |
| Non-Current Liabilities: | ||||||||
| Long Term Debt
| 1,065.4 | 37.44 | 44.82 | 46.98 | 49.94 | 60.11 | 66.3 | 59.16 |
| Deferred Revenue Non-Current
| 346.79 | 49.94 | 55.54 | 56.67 | 58.02 | 201.61 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 2,201.23 | 842.03 | 877.6 | 738.81 | 740.54 | 1,075.69 | 957.14 | 0 |
| Other Non-Current Liabilities
| 1,776.98 | -32.61 | -38.21 | -39.34 | -40.69 | -49.6 | 375.76 | 1,246.34 |
| Total Non-Current Liabilities
| 5,390.4 | 896.8 | 939.75 | 803.12 | 807.81 | 1,287.81 | 1,399.2 | 1,305.5 |
| Total Liabilities
| 19,374.03 | 8,188.13 | 6,760 | 5,928.4 | 4,398.04 | 6,615.5 | 5,191.09 | 3,839.34 |
| Equity: | ||||||||
| Preferred Stock
| 0 | 15.59 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 164.71 | 164.7 | 164.3 | 163.59 | 154.95 | 154.95 | 154.95 | 154.95 |
| Retained Earnings
| 67,878.48 | 60,153.88 | 52,343.45 | 40,226.81 | 30,257.18 | 22,527.46 | 18,008.9 | 15,579.26 |
| Accumulated Other Comprehensive Income/Loss
| 87,073.72 | -15.59 | 114.54 | 240.93 | 160.28 | 47.64 | 49.8 | 14.18 |
| Other Total Stockholders Equity
| -67,878.48 | 19,268.64 | 18,953.92 | 18,401.09 | 5,889.94 | 5,889.94 | 5,889.94 | 5,149.72 |
| Total Shareholders Equity
| 87,238.43 | 79,587.22 | 71,576.21 | 59,032.42 | 36,462.35 | 28,619.99 | 24,103.59 | 20,898.11 |
| Total Equity
| 87,238.43 | 79,587.22 | 71,576.21 | 59,032.42 | 36,462.35 | 28,619.99 | 24,103.59 | 20,898.11 |
| Total Liabilities & Shareholders Equity
| 106,612.46 | 87,775.35 | 78,336.21 | 64,960.82 | 40,860.39 | 35,235.49 | 29,294.68 | 24,737.45 |